n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide has been researched along with Cranial Nerve II Injuries in 1 studies
N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide: thrombin inhibitor; RN given refers to parent cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedmann, I | 1 |
| Yoles, E | 1 |
| Schwartz, M | 1 |
1 other study available for n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Thrombin attenuation is neuroprotective in the injured rat optic nerve.
Topics: Administration, Topical; Animals; Antithrombins; Dipeptides; Nerve Crush; Nerve Degeneration; Neurop | 2001 |